Video: Tim Cunniff of Lundbeck on #OrphanDrugs and CNS business models

Tim Cunniff of Lundbeck on orphan drugs and CNS business models Tim Cunniff, Vice President of Global Regulatory Affairs at Lundbeck, presented at last year's World Orphan Drug Congress USA on the topic ‘Incorporating orphan indications into a CNS business model.'

Do you want to learn more about:

  • Lundbeck’s experience in the orphan drugs space
  • Key considerations in combining orphan indications into a broader CNS strategy
  • Overcoming challenges from clinical development through commercialization

If so, you need to check out the video below:

For more information on orphan drugs and rare diseases, check out the World Orphan Drug Congress USA. Remember, the earlier you book, the more you save, so register now to secure your seat!

Leave a Reply

Your email address will not be published. Required fields are marked *